Broad-spectrum antibiotics are often implemented early and aggressively in hospital settings to correct suspected serious ailments. But what comes later is equally essential.
It is observed that antibiotics are most commonly raised but not de-escalated in a timely manner, at times when clinical stability improves or culture findings reappear.
Why Does This Happen?
Several factors contribute:
-
Fear of undertreating serious infections
-
Delayed culture reporting
-
Defensive prescribing practices
-
Lack of structured antimicrobial stewardship follow-up
-
Time pressure during ward rounds
Escalation feels safe. De-escalation feels risky.
Why It Matters
Failure to step down therapy can lead to:
-
Antimicrobial resistance
-
Increased risk of Clostridioides difficile infection
-
Drug toxicity
-
Higher healthcare costs
-
Disruption of normal microbiota
Ironically, aggressive initial treatment may be justified, but continued broad coverage may not be.
The Real Challenge
Antibiotic stewardship is not just about implementing the appropriate drug.
It’s about asking, every day:
“Can we narrow, reduce, or stop this antibiotic safely?”
De-escalation requires clinical confidence, microbiological support, and system-level accountability.
Like medication reconciliation, should antibiotic de-escalation be considered a daily checkpoint in hospital practice?
MBH/PS